Angiosarcoma after breast-conserving therapy: Long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART)

References

• Abbott R, Palmieri C. Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. Nat Clin Pract Oncol 2008;5:727–36.
   PubMedGoogle Scholar
• Biswas T, Tang P, Muhs A, Ling M. Angiosarcoma of the breast: A rare clinicopathological entity. Am J Clin Oncol 2009;32:582–6.
   PubMed Web of Science ®Google Scholar
• Jallali N, James S, Searle A, Ghattaura A, Hayes A, Harris P. Surgical management of radiation-induced angiosarcoma after breast conservation therapy. Am J Surg 2012;203: 156–61.
   PubMed Web of Science ®Google Scholar
• Marchal C, Weber B, de Lafontan B, Resbeut M, Mignotte H, du Chatelard PP, et al. Nine breast angiosarcomas after conservative treatment for breast carcinoma: A survey from French comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 1999;44:113–9.
   PubMed Web of Science ®Google Scholar
• Wang XY, Jakowski J, Tawfik OW, Thomas PA, Fan F. Angiosarcoma of the breast: A clinicopathologic analysis of cases from the last 10 years. Ann Diagn Pathol 2009; 13:147–50.
   PubMed Web of Science ®Google Scholar
• Palta M, Morris CG, Grobmyer SR, Copeland EM, 3rd, Mendenhall NP. Angiosarcoma after breast-conserving therapy: Long-term outcomes with hyperfractionated radiotherapy. Cancer 2010;116:1872–8.
   PubMed Web of Science ®Google Scholar
• Santi R, Cetica V, Franchi A, Pepi M, Cesinaro AM, Miracco C, et al. Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy. Histopathology 2011;58:455–66.
   PubMed Web of Science ®Google Scholar
• Fernandez AP, Sun Y, Tubbs RR, Goldblum JR, Billings SD. FISH for MYC amplification and anti-MYC immunohistochemistry: Useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol 2012;39:234–42.
   PubMed Web of Science ®Google Scholar
• Manner J, Radlwimmer B, Hohenberger P, Mossinger K, Kuffer S, Sauer C, et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 2010;176:34–9.
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang L, Chang NE, Singer S, Maki RG, Antonescu CR. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Gene Chromosome Cancer 2011;50:25–33.
   PubMed Web of Science ®Google Scholar
• Mentzel T, Schildhaus HU, Palmedo G, Buttner R, Kutzner H. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: Clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol 2012;25:75–85.
   PubMed Web of Science ®Google Scholar
• Lindford A, Bohling T, Vaalavirta L, Tenhunen M, Jahkola T, Tukiainen E. Surgical management of radiation-associated cutaneous breast angiosarcoma. J Plast Reconstr Aesthet Surg 2011;64:1036–42.
   PubMed Web of Science ®Google Scholar
• Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast- conserving surgery and radiation: An analysis of 27 cases. Am J Surg Pathol 2004;28:781–8.
   PubMed Web of Science ®Google Scholar
• Mery CM, George S, Bertagnolli MM, Raut CP. Secondary sarcomas after radiotherapy for breast cancer: Sustained risk and poor survival. Cancer 2009;115:4055–63.
   PubMed Web of Science ®Google Scholar
• Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948;1:64–81.
   PubMed Web of Science ®Google Scholar
• Gambini D, Visintin R, Locatelli E, Galassi B, Bareggi C, Runza L, et al. Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma. Tumori 2009; 95:828–31.
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz E, Ribelles N, Sanchez-Munoz A, Roman A, Marquez A. Response to paclitaxel in a radiotherapy-induced breast angiosarcoma. Acta Oncol 2009;48:1078–9.
   PubMed Web of Science ®Google Scholar
• Arnaout A, Wedman DM, El-Sayed S, Acharya V, Lad S. Neoadjuvant gemcitabine-taxane chemotherapy for radiation-induced angiosarcoma of the breast: A case report. Breast J 2012;18:276–8.
   PubMed Web of Science ®Google Scholar
• Raina V, Sengar M, Shukla NK, Deo SS, Mohanty BK, Sharma D, et al. Complete response from thalidomide in angiosarcoma after treatment of breast cancer. J Clin Oncol 2007;25:900–1.
   PubMed Web of Science ®Google Scholar
• Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX Study. J Clin Oncol 2008;26:5269–74.
   PubMed Web of Science ®Google Scholar
• Morgan EA, Kozono DE, Wang Q, Mery CM, Butrynski JE, Baldini EH, et al. Cutaneous radiation-associated angiosarcoma of the breast: Poor prognosis in a rare secondary malignancy. Ann Surg Oncol 2012;19:3801–8.
   PubMed Web of Science ®Google Scholar
• Seinen JM, Styring E, Verstappen V, Vult von Steyern F, Rydholm A, Suurmeijer AJ, et al. Radiation-associated angiosarcoma after breast cancer: High recurrence rate and poor survival despite surgical treatment with R0 resection. Ann Surg Oncol 2012;19:2700–6.
   PubMed Web of Science ®Google Scholar
• West JG, Weitzel JN, Tao ML, Carpenter M, West JE, Fanning C. BRCA mutations and the risk of angiosarcoma after breast cancer treatment. Clin Breast Cancer 2008; 8:533–7.
   PubMed Web of Science ®Google Scholar
• West JG, Qureshi A, West JE, Chacon M, Sutherland ML, Haghighi B, et al. Risk of angiosarcoma following breast conservation: A clinical alert. Breast J 2005;11:115–23.
   PubMed Web of Science ®Google Scholar